Crossmark

Donor-source-specific competing risks of relapse and non-relapse mortality in adult B-ALL allogeneic hematopoietic stem cell transplantation on a rabbit antithymocyte globulin-based platform

Crossref DOI link: https://doi.org/10.1007/s00277-026-07162-2

Published Online: 2026-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Choi, Dae-Ho

Jung, Chul Won

Jang, Jun Ho
License Information

Text and Data Mining valid from 2026-07-22

Accepted Manuscript valid from 2026-07-22
More Information

Article History

Received: 21 April 2026

Accepted: 29 June 2026

First Online: 22 July 2026

Declarations

Ethics approval and consent to participate: This study was conducted in accordance with the ethical principles of the Declaration of Helsinki (as revised in 2013). Approval was obtained from the Institutional Review Board of Samsung Medical Center (IRB No. 2026-03-102-001). The requirement for individual informed consent was waived by the IRB given the retrospective design.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below